Suppr超能文献

种族/族裔与前列腺癌初始治疗中接受观察等待的情况

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

作者信息

Shavers Vickie L, Brown Martin L, Potosky Arnold L, Klabunde Carrie N, Davis W W, Moul Judd W, Fahey Angela

机构信息

Applied Research Program National Cancer Institute, Bethesda, MD 20892, USA.

出版信息

J Gen Intern Med. 2004 Feb;19(2):146-55. doi: 10.1111/j.1525-1497.2004.30209.x.

Abstract

INTRODUCTION

Several recent studies have noted that African Americans disproportionately receive "watchful waiting" for the initial management of their prostate cancer. To determine whether racial/ethnic differences in the receipt of watchful waiting are explained by differences in clinical presentation and life expectancy at the time of diagnosis, we examined Surveillance, Epidemiology, and End Results (SEER)-Medicare data for men diagnosed with prostate cancer in 1994 to 1996.

METHODS

Race/ethnicity, comorbidity, stage, grade, age, and expected lifespan and their association with the receipt of watchful waiting were examined in multivariate logistic regression analyses. Race-stratified logistic regression analyses were also used to examine racial/ethnic variation in the association of clinical and demographic factors with the receipt of watchful waiting among African-American, Hispanic, and non-Hispanic white men.

RESULTS

African-American (odds ratio [OR], 1.4; 95% confidence interval [CI], 1.3 to 1.6) and Hispanic men (OR, 1.3; 95% CI, 1.1 to 1.5) were significantly more likely than non-Hispanic white men to receive watchful waiting in a multivariate model adjusted for age, comorbidity, stage, grade, and life expectancy. Advanced stage and grade, lower life expectancy, older age, and high comorbidity indices were also significantly associated with an increase in the odds of receipt of watchful waiting in multivariate analyses. In general, the association between the receipt of watchful waiting and the clinical characteristics (i.e., stage, grade, and age) were similar for the three racial/ethnic groups. In race-stratified logistic regression analyses, life expectancy was associated with an increase in the odds of receiving watchful waiting but results were statistically significant for whites only. There was also a statistically significant increase in the odds of receiving watchful waiting for African-American and white men with high comorbidity indices but not Hispanic men. The odds of receiving watchful waiting were also higher for African-American and Hispanic men who resided in census tracts where a large percentage of residents had not completed high school than for white men who resided in similar census tracts.

CONCLUSION

The disproportionate receipt of watchful waiting among African Americans and Hispanics is not completely explained by racial/ethnic variation in clinical characteristics or life expectancy as measured in this study. These data suggest that there are other factors that contribute to racial/ethnic differences in receipt of watchful waiting that warrant investigation.

摘要

引言

最近的几项研究指出,非裔美国人在前列腺癌初始治疗时接受“观察等待”的比例过高。为了确定在接受观察等待方面的种族/族裔差异是否可以通过诊断时的临床表现和预期寿命差异来解释,我们研究了1994年至1996年被诊断为前列腺癌的男性的监测、流行病学和最终结果(SEER)-医疗保险数据。

方法

在多变量逻辑回归分析中,研究了种族/族裔、合并症、分期、分级、年龄、预期寿命及其与接受观察等待的关联。种族分层的逻辑回归分析也用于研究非裔美国人、西班牙裔和非西班牙裔白人男性中临床和人口统计学因素与接受观察等待之间关联的种族/族裔差异。

结果

在根据年龄、合并症、分期、分级和预期寿命进行调整的多变量模型中,非裔美国人(优势比[OR],1.4;95%置信区间[CI],1.3至1.6)和西班牙裔男性(OR,1.3;95%CI,1.1至1.5)比非西班牙裔白人男性更有可能接受观察等待。在多变量分析中,晚期和高分级、较低的预期寿命、较高的年龄和高合并症指数也与接受观察等待的几率增加显著相关。总体而言,三个种族/族裔群体在接受观察等待与临床特征(即分期、分级和年龄)之间的关联相似。在种族分层的逻辑回归分析中,预期寿命与接受观察等待的几率增加相关,但仅对白种人具有统计学意义。合并症指数高的非裔美国人和白人男性接受观察等待的几率也有统计学意义的增加,但西班牙裔男性没有。居住在居民未完成高中学业比例高的普查区的非裔美国人和西班牙裔男性接受观察等待的几率也高于居住在类似普查区的白人男性。

结论

本研究中所衡量的临床特征或预期寿命的种族/族裔差异并不能完全解释非裔美国人和西班牙裔在接受观察等待方面的比例失衡。这些数据表明,还有其他因素导致了接受观察等待方面的种族/族裔差异,值得进行调查。

相似文献

1
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
J Gen Intern Med. 2004 Feb;19(2):146-55. doi: 10.1111/j.1525-1497.2004.30209.x.
2
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Med Care. 2004 Mar;42(3):239-50. doi: 10.1097/01.mlr.0000117361.61444.71.
4
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
J Natl Cancer Inst. 2001 Mar 7;93(5):388-95. doi: 10.1093/jnci/93.5.388.
5
Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
JAMA Netw Open. 2020 Dec 1;3(12):e2031349. doi: 10.1001/jamanetworkopen.2020.31349.
6
Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Cancer. 2005 Feb 1;103(3):538-45. doi: 10.1002/cncr.20796.
8
Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
Urol Pract. 2024 May;11(3):538-546. doi: 10.1097/UPJ.0000000000000529. Epub 2024 Apr 19.
9
Racial Disparities in Active Surveillance for Prostate Cancer.
J Urol. 2017 Feb;197(2):342-349. doi: 10.1016/j.juro.2016.08.104. Epub 2016 Sep 3.

引用本文的文献

1
Understanding and Addressing Prostate Cancer Disparities in Diagnosis, Treatment, and Outcomes Among Black Men.
Cancer Control. 2024 Jan-Dec;31:10732748241275389. doi: 10.1177/10732748241275389.
4
A narrative review of socioeconomic disparities in the treatment of esophageal cancer.
J Thorac Dis. 2021 Jun;13(6):3801-3808. doi: 10.21037/jtd-20-3095.
6
Trends in treatments for prostate cancer in the United States, 2010-2015.
Am J Cancer Res. 2021 May 20;11(5):2351-2368. eCollection 2021.
9
Racial disparities and considerations for active surveillance of prostate cancer.
Transl Androl Urol. 2018 Apr;7(2):214-220. doi: 10.21037/tau.2017.09.11.

本文引用的文献

1
Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.
Am J Public Health. 2002 Oct;92(10):1606-9. doi: 10.2105/ajph.92.10.1606.
2
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
N Engl J Med. 2002 Sep 12;347(11):781-9. doi: 10.1056/NEJMoa012794.
3
Utility of the SEER-Medicare data to identify chemotherapy use.
Med Care. 2002 Aug;40(8 Suppl):IV-55-61. doi: 10.1097/01.MLR.0000020944.17670.D7.
4
Studying radiation therapy using SEER-Medicare-linked data.
Med Care. 2002 Aug;40(8 Suppl):IV-49-54. doi: 10.1097/00005650-200208001-00007.
5
Use of SEER-Medicare data for measuring cancer surgery.
Med Care. 2002 Aug;40(8 Suppl):IV-43-8. doi: 10.1097/00005650-200208001-00006.
8
Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
BJU Int. 2002 Aug;90(3):257-64. doi: 10.1046/j.1464-410x.2002.02846.x.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验